12275 Effect Of Osilodrostat On Cardiovascular And Metabolic Manifestations Of Hypercortisolism In Patients With Non-Pituitary Cushing’s Syndrome: Findings From A Retrospective Observational Study (LINC 7)
N Scheyer(Centre Hospitalier Régional et Universitaire de Nancy), A. Tabarin(Centre Hospitalier Universitaire de Bordeaux), Jérôme Bertherat(Centre National de la Recherche Scientifique), C Vaillant(Centre Hospitalier du Mans), D. Drui(Centre Hospitalier Universitaire de Nantes), Bénédicte Decoudier(Centre Hospitalier Universitaire de Reims), Hervé Lefèbvre(Inserm), Nicolas Chevalier(Inserm), Justine Cristante(Centre Hospitalier Universitaire de Grenoble), Wence Agbotounou(DBV Technologies (France)), Amber L. Mueller(Harvard University), Hélène Lasolle(Hospices Civils de Lyon), Sarah Fodil-Cherif(Centre Hospitalier Universitaire de Montpellier), A Antonellini(Recordati (Italy)), J. Morera(Centre Hospitalier Universitaire de Caen Normandie), Frédéric Castinetti(Inserm)
Cited by 2
Related Papers
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
|Cancer Cell|2016|665
SDHA is a tumor suppressor gene causing paraganglioma
|Human Molecular Genetics|2010|651